Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infectionSARS-CoV-2 감염 입원 환자의 토실리주맙 실패 예측 모델 개발 및 검증Research Article Published on 2021-02-232022-09-12 Journal: PLoS ONE [Category] 진단, [키워드] Accuracy Analysis assist AUC clinician Cohort composite endpoint Course CRP death develop development died Factor Follow-up generate hospital hospitalized patient identify identifying inclusion criteria independent logistic regression model mechanical ventilation Mortality multicenter cohort study multivariable analysis multivariable logistic regression models outcome PaO Patient patients treated Platelet Platelets post treatment predictor receiving Result retrospective risk SARS-COV-2 infection secondary secondary outcome selected severe pneumonia Sex Standard of care study outcome study outcomes TESEO Therapies Tocilizumab tocilizumab administration treatment initiation treatment with tocilizumab validation cohort were used with COVID-19 [DOI] 10.1371/journal.pone.0247275 PMC 바로가기 [Article Type] Research Article
Delayed Presentation of Patients with Hip Fractures during the COVID-19 “Stay-at-Home” Order in the Southmost Region of the United StatesResearch Article Published on 2021-02-162022-10-28 Journal: Advances in Orthopedics [Category] COVID-19, [키워드] age Analysis average body mass index Care center Characteristics clinical outcomes cohort study Comorbidities complications conducted COVID-19 COVID-19 test Delayed Diagnosis discharge evaluate the effect females Fracture functional hip Hispanic ethnicity hospital resources ICU increase in Injury intensive care interfere level 2 mechanism Mortality MOST National not affected occurred Older outcome Patient patients postoperative presentation presenting Region rehabilitation facility reported retrospective Sex significantly study outcome the patient the United State Treatment [DOI] 10.1155/2021/8822004 PMC 바로가기 [Article Type] Research Article
Socioeconomic disparities in Korea by health insurance type during the COVID-19 pandemic: a nationwide study코로나19 팬데믹 기간 한국의 건강보험 유형별 사회경제적 격차: 전국 조사COVID-19 Published on 2021-01-132022-09-12 Journal: Epidemiology and Health [Category] MERS, 진단, [키워드] 95% CI 95% confidence interval acute respiratory syndrome Admission age Analysis CCI CIs Cohort Comorbidity conducted coronavirus coronavirus disease COVID-19 COVID-19 tests database death determinant diagnostic elevated event group had no Health Health insurance type healthcare increased risk individual Infection insurance intensive care male mechanical ventilation Medicaid multivariable logistic regression Odds ratio Older outcome outcomes pandemic positive retrospective cohort study risk SARS-CoV-2 SARS-COV-2 infection sex- significantly Socioeconomic disparities Socioeconomic Factors Spread study outcome Support tested [DOI] 10.4178/epih.e2021007 PMC 바로가기 [Article Type] COVID-19
The vitamin D for COVID-19 (VIVID) trial: A pragmatic cluster-randomized designRandomized Controlled Trial Published on 2021-01-012022-10-05 Journal: Contemporary clinical trials [Category] SARS, 임상, [키워드] 1:1 approach change changes in Cluster cluster design Cluster randomization Contact COVID-19 COVID-19 infection determine diagnosed Disease progression double-blinded early treatment High-dose Hospitalization household contacts include individual individuals with COVID-19 Infection Intervention Loading dose Mortality Occurrence Placebo Pragmatic preventing infection Primary outcome Prophylaxis provide Randomized reduce reducing risk risk of COVID-19 SARS-CoV-2 secondary outcome Seroconversion study outcome symptom severity score Trial Vitamin D Vitamin D supplementation [DOI] 10.1016/j.cct.2020.106176 PMC 바로가기 [Article Type] Randomized Controlled Trial
Elevated cardiac biomarkers may be effective prognostic predictors for patients with COVID-19: A multicenter, observational studyResearch article Published on 2021-01-012022-10-05 Journal: The American journal of emergency medicine [Category] 바이오마커, [키워드] Admission adverse outcomes AUC Biomarker cardiac characteristic CK-MB combined use coronavirus disease COVID-19 COVID-19 patients Creatine kinase isoenzyme death group early stages effective elevated evaluated Follow-up Health In-hospital death independent involved multicenter Myoglobin Patient patients with COVID-19 predictor Prognosis prognostic regression analysis Result risk Risk predictors ROC selected study outcome survival group [DOI] 10.1016/j.ajem.2020.10.013 [Article Type] Research article
Cardiovascular complications in COVID‐19 patients with or without diabetes mellitusOriginal Research Article Published on 2020-12-252022-10-31 Journal: Endocrinology, Diabetes & Metabolism [Category] Coronavirus, MERS, SARS, [키워드] Acute heart failure Acute myocardial infarction adjusted adjusted odds ratio age Atrial fibrillation baseline cardiovascular cardiovascular complication cardiovascular complications Comorbidities Complication confounding variables Coronavirus disease 2019 COVID‐19 COVID‐19 patient COVID‐19 demographics Diabetes Mellitus diabetic patient Endpoint glycaemic control higher odd include indicated investigated less Logistic regression magnitude medications multivariate myocarditis Older outcome Patient patients patients with diabete receive Result Sex significantly higher stratified study outcome was used [DOI] 10.1002/edm2.218 PMC 바로가기 [Article Type] Original Research Article
Evaluating the efficacy and safety of the myrtle ( Myrtus communis ) in treatment and prognosis of patients suspected to novel coronavirus disease (COVID-19): study protocol for a randomized controlled trialRandomized Controlled Trial Published on 2020-11-262022-10-04 Journal: Trials [Category] SARS, 임상, [키워드] M. communis addition adverse effect age China clinical clinical status clinically suspected Coronavirus pneumonia COVID-19 COVID-19 disease disease distress Efficacy Efficacy and safety evaluated Evaluating Evidence Herb identify in both group manuscript Mild moderate mortality rate Myrtle Myrtus communis novel coronavirus disease Open-label outbreak Outpatient Persian medicine prognosis of patient protocol Randomized controlled trial receive Registered registry study outcome Study protocol Symptom therapeutic therapy Treatment Trial website [DOI] 10.1186/s13063-020-04915-w PMC 바로가기 [Article Type] Randomized Controlled Trial
Derivation and validation of the clinical prediction model for COVID-19Im - Original Published on 2020-09-152022-10-30 Journal: Internal and Emergency Medicine [Category] COVID-19, [키워드] Admission Care Characteristics Clinical data clinical evolution Clustering consecutive patient Coronavirus disease 2019 COVID-19 COVID-19 patient Critical illness derivation Derivation score eight Epidemic four groups health system hospital ICU ICU admission identify implementation in-hospital mortality in-hospital mortality rate initial laboratory-confirmed management Patient patients Predictive Predictive-markers resource Respiratory failure risk SARS-CoV2 score severe interstitial pneumonia severity specific treatment study outcome study outcomes treated Validation score [DOI] 10.1007/s11739-020-02480-3 PMC 바로가기 [Article Type] Im - Original
Coronavirus disease 2019 (COVID-19) related cytopenia A protocol for systematic review and meta-analysis4900 Published on 2020-09-042022-10-30 Journal: Medicine [Category] COVID-19, SARS, [키워드] abnormality acute respiratory syndrome approval available data bias risk caused CNKI Cochrane Library collected Consensus coronavirus Coronavirus disease 2019 COVID-19 COVID-19 patient COVID-19 patients cytopenia data extraction database determine Effectiveness Efficacy evaluate Evidence Google Scholar help hematological hemoglobin International limitation lymphopenia Meta-analysis Mortality Novel coronavirus outbreak outcome patients with COVID-19 peer-reviewed performed Pneumonia prognostic protocol recent Region researcher resolved Respiratory illness searched selected study outcome systematic review Systemic review was performed Web of Science Wuhan [DOI] 10.1097/MD.0000000000022033 PMC 바로가기 [Article Type] 4900
Are hydroxychloroquine and chloroquine effective in the treatment of SARS-COV-2 (COVID-19)? Reviews Published on 2020-06-262022-10-05 Journal: Evidence-based dentistry [Category] 임상, [키워드] carried Chloroquine comparable COVID-19 data extraction database drug effective Effectiveness Efficacy exclusion criteria help heterogeneity high quality evidence highlight humans Hydroxychloroquine Inclusion Interim report item limitations manuscript methodological limitations methodology narrative national guidelines non-randomised trial Open-label outcome outcomes parameters prospective cohort study randomised controlled trial Randomised controlled trials recommendation regimen reported Reporting Result review statistical analysis statistically significant difference study outcome suggested Treatment use of hydroxychloroquine were excluded [DOI] 10.1038/s41432-020-0098-2 [Article Type] Reviews